TY - JOUR T1 - Early origins of lung disease: towards an interdisciplinary approach JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW DO - 10.1183/16000617.0191-2020 VL - 29 IS - 157 SP - 200191 AU - Niki D.J. Ubags AU - Miguel A. Alejandre Alcazar AU - Suhas G. Kallapur AU - Sylvia Knapp AU - Sophie Lanone AU - Clare M. Lloyd AU - Rory E. Morty AU - Céline Pattaroni AU - Niki L. Reynaert AU - Robbert J. Rottier AU - Hermelijn H. Smits AU - Wouter A.A. de Steenhuijsen Piters AU - Deborah H. Strickland AU - Jennifer J.P. Collins Y1 - 2020/09/30 UR - http://err.ersjournals.com/content/29/157/200191.abstract N2 - The prenatal and perinatal environments can have profound effects on the development of chronic inflammatory diseases. However, mechanistic insight into how the early-life microenvironment can impact upon development of the lung and immune system and consequent initiation and progression of respiratory diseases is still emerging. Recent studies investigating the developmental origins of lung diseases have started to delineate the effects of early-life changes in the lung, environmental exposures and immune maturation on the development of childhood and adult lung diseases. While the influencing factors have been described and studied in mostly animal models, it remains challenging to pinpoint exactly which factors and at which time point are detrimental in lung development leading to respiratory disease later in life. To advance our understanding of early origins of chronic lung disease and to allow for proper dissemination and application of this knowledge, we propose four major focus areas: 1) policy and education; 2) clinical assessment; 3) basic and translational research; and 4) infrastructure and tools, and discuss future directions for advancement. This review is a follow-up of the discussions at the European Respiratory Society Research Seminar “Early origins of lung disease: towards an interdisciplinary approach” (Lisbon, Portugal, November 2019).Future research into early origins of lung disease should be centred around four major focus areas: 1) policy and education, 2) clinical assessment, 3) basic and translational research and 4) infrastructure and tools https://bit.ly/2FHqWmP ER -